Financial Reports Investor newsFinancial reportsInvest in InifyCompany overviewCorporate governanceExecutive teamBoard of directorsSustainabilityThe shareFinancial calendarContactsSubscription All20252024202320222021Annual reports2025-04-30Inify Laboratories: Continued strong growth – construction and establishment in the UKDownload2025-04-16Inify Laboratories - Annual Report 2024Download2025-02-26Inify Laboratories: 60% quarterly sales growth and highly positive response to UK expansionDownload2024-10-23Inify Laboratories: Establishment in the United Kingdom and expansion into gastrointestinal diagnosticsDownload2024-08-21INIFY Laboratories: 62% revenue growth and strong international interestDownload2024-04-24Inify Laboratories - More diagnoses delivered in the first quarter than in the whole of 2023Download2024-04-24Inify Laboratories - More diagnoses delivered in the first quarter than in the whole of 2023Download2024-04-11Inify Laboratories - Annual Report 2023Download2024-02-29Foresees a noticeable increase of customers, volume, and sales in 2024Download2023-10-24Continuous diagnostic operation and very positive feedback from customersDownload2023-08-23Inify Laboratories - Successful laboratory launch in Q2 with delivery of first prostate cancer diagnosisDownload2023-04-26Inify Laboratories - Strong market interest and launch on trackDownload2023-04-12Inify Laboratories - Annual Report 2022Download2023-02-22Inify Laboratories - Ultramodern AI-based digital pathology laboratory completed in record timeDownload2022-10-26Inify Laboratories - Laboratory and recruitment on track with positive market feedbackDownload2022-08-17Inify’s first ultramodern laboratory on trackDownload2021-10-21Aiming to build the company’s first modern pathology labDownload Swedish financial reports